Additional information
Light yellow Powder
NA
ACI-011246
60.3-62.2°C
C21H21FO4
356.4
Ambient
2-8°C
Cardiovascular
Pharmaceutical Impurity Standards
methyl 2-(2-(2-fluorophenyl)-2-oxo-1-phenylethyl)-4-methyl-3-oxopentanoate
methyl 2-(2-(2-fluorophenyl)-2-oxo-1-phenylethyl)-4-methyl-3-oxopentanoate
Benzenebutanoic acid, 2-fluoro-?-(2-methyl-1-oxopropyl)-?-oxo-?-phenyl-, methyl ester





![N-METHYL REGADENOSON (25 mg) (1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N,N-dimethylpyrazole-4-carboxamide )](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)